Research and Markets (http://www.researchandmarkets.com/research/zw29tf/rhinoconjunctivit) has announced the addition of the "Rhino-Conjunctivitis-Pipeline Insights, 2016" report to their offering.

Rhino-Conjunctivitis-Pipeline Insights, 2016 provides in depth insights on the pipeline drugs and their development activities around the Rhino-Conjunctivitis. The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.

Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.

The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Rhino-Conjunctivitis.

The report also assesses the Rhino-Conjunctivitis therapeutics by Monotherapy, Combination products, molecule type and Route of Administration.

Scope

  • The report provides competitive pipeline landscape of Rhino-Conjunctivitis
  • The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
  • Coverage of the Rhino-Conjunctivitis pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • The report reviews key players involved in the therapeutics development for Rhino-Conjunctivitis and also provide company profiling
  • The report also gives the information of dormant and discontinued pipeline projects
  • Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Key Topics Covered:

  1. Rhino-Conjunctivitis Overview
  2. Rhino-Conjunctivitis Pipeline Therapeutics
  3. Rhino-Conjunctivitis Therapeutics under Development by Companies
  4. Rhino-Conjunctivitis Filed and Phase III Products
  5. Comparative Analysis
  6. Rhino-Conjunctivitis Phase II Products
  7. Rhino-Conjunctivitis Phase I and IND Filed Products
  8. Rhino-Conjunctivitis Discovery and Pre-Clinical Stage Products
  9. Rhino-Conjunctivitis - Therapeutics Assessment
  10. Assessment by Monotherapy Products
  11. Assessment by Combination Products
  12. Assessment by Route of Administration
  13. Assessment by Molecule Type
  14. Rhino-Conjunctivitis - Discontinued Products
  15. Rhino-Conjunctivitis - Dormant Products
  16. Companies Involved in Therapeutics Development for Rhino-Conjunctivitis

For more information visit http://www.researchandmarkets.com/research/zw29tf/rhinoconjunctivit